• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees

 

FDA

 

FDA- GBCA & NSF Core Presentation (pdf)

 

 

******************************************

 

Bayer

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

 

Bayer- Magnevist (Gadopentetate Dimeglumine) Core Presentation (pdf)

 

Bayer- Eovist (Gadoxetate Disodium) Core Presentation (pdf)

 

*******************************************

 

Bracco Diagnostics Inc

 

Bracco- Prohance (Gadoteridol) Injection Core Presentation (pdf)

 

Bracco- Multihance (Gadobenate Dimeglumine) Injection Core Presentation (pdf)

 

******************************************

 

GE Healthcare

 

GE- Safety of Omniscan (Gadodiamide) Injection for Intravenous Use Core Presentation (pdf)

 

GE- Safety of Omniscan (Gadodiamide) Injection for Intravenous Use Backup Presentation (pdf)

 

******************************************

 

Covidien Pharmaceuticals

 

Covidien- Optimark (Gadoversetamide Injection) Core Presentation (pdf)

 

******************************************

 

Lantheus Medical Imaging, Inc

 

Lantheus- Ablavar Core Presentation (pdf)

 

Lantheus- Ablavar Backup Presentation (pdf)

 

******************************************

 

Guest Speaker

 

GUEST- Core Presentation (pdf)

 

******************************************

 

OPH

 

OPH- Core Presentation (pdf)